Results 81 to 90 of about 16,262,576 (403)

Addressing Vaccine Inequity - Covid-19 Vaccines as a Global Public Good.

open access: yesNew England Journal of Medicine, 2022
David J. Hunter   +7 more
semanticscholar   +1 more source

Privacy as a Public Good [PDF]

open access: yes, 2015
Privacy is commonly studied as a private good: my personal data is mine to protect and control, and yours is yours. This conception of privacy misses an important component of the policy problem.
Engel, Christoph   +1 more
core   +1 more source

Exploring intergenerational knowledge transfer within Inuvialuit families: connecting wellbeing, food security, and climate resiliency

open access: yesFrontiers in Climate
IntroductionToday in the Inuvialuit Settlement Region, Canada, many community members are closely connected to and dependent on the land, with 68.9% of Indigenous people in the ISR indicating that they fished and harvested in 2023.
Maria Ramirez Prieto   +7 more
doaj   +1 more source

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

open access: yesMolecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian   +10 more
wiley   +1 more source

Impact of artificial liver plasma perfusion combined with plasma exchange therapy on clinical efficacy and short-term prognosis of hepatitis B virus-related acute-on-chronic liver failure with or without HIV infection

open access: yesBMC Infectious Diseases
Objective To compare the effectiveness of plasma perfusion combined with plasma exchange (PP + PE) artificial liver support system in patients with hepatitis B virus-associated acute-on-chronic liver failure with and without HIV infection (HBV-ACLF/HIV(+)
Ming Zhou   +6 more
doaj   +1 more source

Jean Tirole: Mathematician-Economist-Humanist

open access: yesФинансы: теория и практика, 2019
Jean Tirole, the Nobel Prize winner in Economic Sciences in 2014, who in November 2018 visited the Financial university in Moscow, presents one of the most striking examples of the evolution currently experienced by some modern economists. He started his
Z. Mierzwa
doaj   +1 more source

Integrated genomic and proteomic profiling reveals insights into chemoradiation resistance in cervical cancer

open access: yesMolecular Oncology, EarlyView.
A comprehensive genomic and proteomic analysis of cervical cancer revealed STK11 and STX3 as a potential biomarkers of chemoradiation resistance. Our study demonstrated EGFR as a therapeutic target, paving the way for precision strategies to overcome treatment failure and the DNA repair pathway as a critical mechanism of resistance.
Janani Sambath   +13 more
wiley   +1 more source

Local Public Good Provision, Municipal Consolidation, and National Transfers [PDF]

open access: yes, 2006
We analyze a simple model of local public good provision in a country consisting of a large number of heterogeneous regions, each comprising two districts, a city and a village.
Dur, Robert, Staal, Klaas
core   +3 more sources

The Ecology of Economic Distress and Life Expectancy

open access: yesInternational Journal of Public Health
ObjectivesTo determine whether life expectancy (LE) changes between 2000 and 2019 were associated with race, rural status, local economic prosperity, and changes in local economic prosperity, at the county level.MethodsBetween 12/1/22 and 2/28/23, we ...
William Brinson Weeks   +5 more
doaj   +1 more source

Gut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy

open access: yesMolecular Oncology, EarlyView.
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy